Medical Digest & Congress Report

Professor Dereck Connolly shares his insights on LDL lowering in 2025 at the 4th World Congress of Lipidology in Vienna, Austria. Video: https://medicaldigest.org/scientific-contents/interview:ldl-lowering-2025-optimal-approach

Professor Matthew Matasar explains the highly anticipated results of the Phase III POLARGO trial after the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:polargo-trial-shows-os-benefit-pola-r-gemox-transplant-ineligible-rr-dlbcl

Professor Dennis Kim shares his insights on the asciminib in the treatment of chronic myeloid leukemia after the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:asciminib-treatment-cml

Professor Petya Apostolova shares her insights on the Acute Myeloid Leukemia highlights from the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:aml-highlights-eha-2025

Professor Matthew Davids shares his insights on the advances in post-covalent Bruton`s tyrosine kinase inhibitor therapy for relapsed/refractory chronic lymphocytic leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:advances-post-covalent-brutons-tyrosine-kinase-inhibitor-therapy-relapsedrefractory-chronic-lymphocytic-leukemia

Professor Martin Schrappe shares his insights on the frontline therapy of B-cell acute lymphoblastic leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:frontline-therapy-b-cell-acute-lymphoblastic-leukemia-harnessing-innovative-approaches-improve-outcomes

Professor Martin Hutchings shares his insights on the role of bispecifics int the treatment of diffuse large B cell lymphoma at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:diffuse-large-b-cell-lymphoma-bispecifics-focus

Professor Sam Salek discusses how to educate haematologists to better identify Gaucher disease at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:how-educate-haematologists-better-identify-gaucher-disease

Professor Evangelos Terpos shares his insights on the management of Multiple Myeloma at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:management-multiple-myeloma-eha-2025

Professor Thomas Oellerich shares his insights on the highlights of Diffuse Large B-Cell Lymphoma at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:highlights-diffuse-large-b-cell-lymphoma-eha-2025

Professor Agnieszka Wierzbowska shares her thoughts on emerging insights in the secondary acute myeloid leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:emerging-insights-secondary-acute-myeloid-leukemia-2025

Professor Paul K. Whelton shares his insights on combination therapy for the treatment of hypertension after the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy. Video: https://medicaldigest.org/scientific-contents/interview:combination-therapy-treatment-hypertension

Professor Doris Hansen shares her insights on the role of CAR T-cell therapy in Multiple Myeloma at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:role-car-t-cell-therapy-multiple-myeloma

Professor Andrzej Jakubowiak shares his insights on multiple myeloma updates at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:multiple-myeloma-update-eha-2025

Professor Gail Roboz shares her insights on the treatment landscape in myelodysplastic syndromes and acute myeloid leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:shaping-treatment-landscape-myelodysplastic-syndromes-and-acute-myeloid-leukemia

Professor Cristina Papayannidis shares her insights on the new therapeutic options in acute lymphocytic leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:new-therapeutic-options-and-translational-insights-all

Professor Adolfo de la Fuente Burguera shares his insights on the landscape for FLT3-mutated relapsed/refractory acute myeloid leukaemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:exploring-landscape-flt3-mutated-relapsedrefractory-acute-myeloid-leukaemia

Professor Pilar Giraldo shares her insights on how to improve the awareness in Gaucher disease at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:how-improve-awareness-gaucher-disease

Professor Dima El-Sharkawi shares her insights on the evolving chronic lymphocytic leukemia treatment landscape for the optimal patient journey and experience at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:mapping-evolving-chronic-lymphocytic-leukemia-treatment-landscape-optimal-patient-journey-and-experience

Professor Mark Levis shares his insights on optimising the management of FLT3mut+ R/R AML at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:optimising-management-flt3mut-rr-aml

Professor Sebastian Giebel shares his insights on the Acute Lymphoblastic Leukemia highlights from the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:all-highlights-eha-2025

Professor Lydia Scarfò shares her insights on BTKi-B–cell lymphoma 2 inhibitor options in treatment naïve CLL at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:first-steps-time-limited-btki-bcell-lymphoma-2-inhibitor-options-treatment-naive-cll

Professor Livio Pagano discusses improving patient outcome in secondary acute myeloid leukemia at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:improving-patient-outcome-secondary-acute-myeloid-leukemia-2025

Professor Nicole Lamanna shares her insights on second-generation BTKi combinations at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:second-coming-finite-therapy-chronic-lymphocytic-leukemia

Professor Enrique M. Ocio discusses progress on the treatment of relapsed and refractory multiple myeloma at the 2025 EHA Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:unprecedented-progress-treatment-relapsed-and-refractory-multiple-myeloma-2025